Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

24 Jul 2014 15:28

RNS Number : 2704N
Biome Technologies PLC
24 July 2014
 



 

24 July 2014

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update, ahead of its interim results for the six-month period ended 30 June 2014, which are expected to be announced on 3 September 2014.

 

Trading Update

 

Total Group revenues achieved for the second quarter of 2014 were £1.2m (Q1 2014: £1.1m; Q2 2013: £0.5m). The turnover for the second quarter maintains the significant progress made in the first quarter of 2014 compared to the same period in the prior year and means that revenues generated by the Group in the first half of 2014 at £2.3m are now in excess of those for the full year of 2013.

 

The Group's cash position at 30 June 2014 was £3.1m (31 March 2014: £3.2m).

 

The business continues to make good progress with the strategy to commercialise and develop wholly owned intellectual property. Performance in the first half was ahead of the Board's expectations for both divisions.

 

Bioplastics Division

 

Q2 2014 revenues for the Bioplastics Division were £0.6m (Q1 2014: £0.5m; Q2 2013: £0.1m) 21% ahead of Q1 2014 performance. Revenues generated by the Bioplastics Division in the first half of 2014 were therefore £1.1m, already in excess of the £1.0m full year 2013 revenue.

 

The focus of the division on developing high margin, application led bioplastic polymers with enhanced level of functionality is starting to take hold. Increasing volumes of Biome's materials were procured in the period for use in the US single-serve coffee market amongst other applications. Further progress was made in the development of the pipeline of new products with technical and customer trials continuing in both the food service and paper-board coating sectors.

 

The division announced the successful completion of a feasibility study undertaken in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining and supported by the Government-backed Technology Strategy Board (TSB).

 

Stanelco RF Technologies Division

 

Q2 2014 revenues for the RF Division were £0.6m (Q1 2014: £0.6m; Q2 2013: £0.4m) maintaining the promising start that the division made in the first quarter of the year. Revenues for the first half of 2014 were £1.2m and are now in excess of the revenues achieved by this division for the full year 2013.

 

Activity and ordering levels in the first half have been encouraging with some evidence that the market for fibre optic furnaces, one of the main repeating products for the division, is experiencing some recovery in Asia. The contract with a customer from a regulated industry has commenced and receipts of approximately one quarter of contract value were received during the first half of 2014. Enquiry and order levels for the business are robust.

 

Group Outlook

 

The Group's revenues and cash are slightly ahead of the Board's expectations at the mid-year point with the reporting of the interim results scheduled for 3 September 2014.

 

This has been a positive first half for the Group and the Board is confident that this progress can be maintained for the full year.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

David Hart (Nominated Adviser)

Mark Treharne (Broker)

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

Allenby Capital

Chris Crawford/Kelly Gardiner

www.allenbycapital.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKQDBQBKDOOB
Date   Source Headline
27th Apr 20071:34 pmRNSResult of AGM
27th Apr 20071:32 pmRNSDirectorate Change
26th Apr 20071:42 pmRNSAnnual Information Update
13th Apr 200712:29 pmRNSDirector's Dealing
30th Mar 20071:32 pmRNSAnnual Report and Accounts
23rd Mar 20075:09 pmRNSNotifiable Interest
21st Mar 20077:03 amRNSPreliminary Results
14th Mar 20075:59 pmRNSHolding(s) in Company
26th Feb 20077:01 amRNSBoard Appointment
23rd Feb 20073:18 pmRNSHolding(s) in Company
30th Jan 20079:00 amRNSNotice of Results
18th Dec 20064:58 pmRNSTotal Voting Rights
8th Dec 200612:31 pmRNSNotifiable Interest
28th Nov 20063:32 pmRNSNotifiable Interest
17th Nov 20063:33 pmRNSNotifiable Interest
16th Nov 20069:02 amRNSNotifiable Interest
14th Nov 20064:37 pmRNSDirectorate Change
14th Nov 20064:09 pmRNSDirector/PDMR Shareholding
14th Nov 20064:03 pmRNSNotifiable Interest
14th Nov 20069:55 amRNSNotifiable Interest
10th Nov 200610:29 amRNSHolding(s) in Company
9th Nov 200611:45 amRNSNotifiable Interest
8th Nov 20063:08 pmRNSNotifiable Interest
7th Nov 20068:01 amRNSIssue of Equity
6th Nov 200612:12 pmRNSResult of EGM
3rd Nov 20064:41 pmRNSNotifiable Interest
3rd Nov 20061:17 pmRNSOpen Offer Result - Amendment
2nd Nov 20066:03 pmRNSOpen Offer Result
31st Oct 200611:54 amRNSNotifiable Interest
17th Oct 20065:54 pmRNSNotifiable Interest
17th Oct 200610:44 amRNSNotifiable Interest
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.